Company: SACH
Filing Date: 2025-05-28
Form Type: S-3/A
Source: 0001628280-25-028093
Chunk: 3

Company: Sachem Capital Corp.
Filing Date: 2025-05-28
Form: S-3/A
Chunk 3
---
SCCF”, and “SCCG,” referred to,collectively, in this base prospectus as the “Notes,” and (ii) a 7.75% Series A Cumulative Redeemable Preferred Stock, $0.001 par value per share, listed on the NYSE American under the symbol “SACHPRA,” referred to in this base prospectus as the Series A Preferred Stock.” None of the other Securities are currently listed on any exchange or quoted on any other trading venue or system.

The aggregate market value of our outstanding common shares held by non-affiliates was $52,224,345 based on 45,020,987 outstanding common shares held by non-affiliates on May 15, 2025, and based on the highest reported closing sale price of our common shares of $1.16 per share on April 1, 2025. Pursuant to General Instruction I.B.6 of Form S-3, in no event will we sell Securities pursuant to this base prospectus and any accompanying prospectus supplement with a value of more than one-third of the aggregate market value of our common shares held by non-affiliates in any 12-month period, so long as the aggregate market value of our common shares held by non-affiliates is less than $75,000,000. In the event that subsequent to the date of this base prospectus, the aggregate market value of our outstanding common shares held by non-affiliates equals or exceeds $75,000,000, then the one-third limitation on sales will not apply to additional sales made pursuant to this prospectus. During the prior 12 calendar months prior to, and including, the date of this prospectus, we have not sold any securities pursuant to General Instruction I.B.6 of Form S-3.

#### See “

#### Risk Factors
” in Item 1A of our Annual Report on Form 10-K, filed March 31, 2025, with respect to our year ended December 31, 2024, in Item 1A of each subsequently filed Quarterly Report on form 10-Q (which documents are incorporated by reference herein) as well as the other information contained or incorporated by reference in this base prospectus or any prospectus supplement hereto before making a decision to invest in the Securities. See “ Where You Can Find More Information; Incorporation By Reference

#### ” on page

#### 60

#### of this base prospectus.
Neither the Securities and Exchange Commission nor